489 related articles for article (PubMed ID: 16412866)
1. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.
Santilli F; Davì G; Consoli A; Cipollone F; Mezzetti A; Falco A; Taraborelli T; Devangelio E; Ciabattoni G; Basili S; Patrono C
J Am Coll Cardiol; 2006 Jan; 47(2):391-7. PubMed ID: 16412866
[TBL] [Abstract][Full Text] [Related]
2. Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration.
Davì G; Chiarelli F; Santilli F; Pomilio M; Vigneri S; Falco A; Basili S; Ciabattoni G; Patrono C
Circulation; 2003 Jul; 107(25):3199-203. PubMed ID: 12810609
[TBL] [Abstract][Full Text] [Related]
3. Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost.
Lessiani G; Vazzana N; Cuccurullo C; Di Michele D; Laurora G; Sgrò G; Di Ruscio P; Simeone E; Di Iorio P; Lattanzio S; Liani R; Ferrante E; Davì G
Thromb Haemost; 2011 Feb; 105(2):321-8. PubMed ID: 21103664
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation.
Davì G; Neri M; Falco A; Festi D; Taraborelli T; Ciabattoni G; Basili S; Cuccurullo F; Patrono C
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):246-51. PubMed ID: 15472127
[TBL] [Abstract][Full Text] [Related]
5. Determinants of platelet activation in Alzheimer's disease.
Ciabattoni G; Porreca E; Di Febbo C; Di Iorio A; Paganelli R; Bucciarelli T; Pescara L; Del Re L; Giusti C; Falco A; Sau A; Patrono C; Davì G
Neurobiol Aging; 2007 Mar; 28(3):336-42. PubMed ID: 16442186
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients.
Liani R; Halvorsen B; Sestili S; Handberg A; Santilli F; Vazzana N; Formoso G; Aukrust P; Davì G
Free Radic Biol Med; 2012 Apr; 52(8):1318-24. PubMed ID: 22343420
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance as a determinant of platelet activation in obese women.
Basili S; Pacini G; Guagnano MT; Manigrasso MR; Santilli F; Pettinella C; Ciabattoni G; Patrono C; Davì G
J Am Coll Cardiol; 2006 Dec; 48(12):2531-8. PubMed ID: 17174194
[TBL] [Abstract][Full Text] [Related]
8. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.
Davì G; Ciabattoni G; Consoli A; Mezzetti A; Falco A; Santarone S; Pennese E; Vitacolonna E; Bucciarelli T; Costantini F; Capani F; Patrono C
Circulation; 1999 Jan; 99(2):224-9. PubMed ID: 9892587
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C→T polymorphism.
Dragani A; Falco A; Santilli F; Basili S; Rolandi G; Cerasa L; Lattanzio S; Ciabattoni G; Patrono C; Davì G
Thromb Haemost; 2012 Sep; 108(3):533-42. PubMed ID: 22782530
[TBL] [Abstract][Full Text] [Related]
10. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C
Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention.
Lim HS; Blann AD; Lip GY
Circulation; 2004 Jun; 109(21):2524-8. PubMed ID: 15136493
[TBL] [Abstract][Full Text] [Related]
12. Effects of high-amount-high-intensity exercise on in vivo platelet activation: modulation by lipid peroxidation and AGE/RAGE axis.
Santilli F; Vazzana N; Iodice P; Lattanzio S; Liani R; Bellomo RG; Lessiani G; Perego F; Saggini R; Davì G
Thromb Haemost; 2013 Dec; 110(6):1232-40. PubMed ID: 24030807
[TBL] [Abstract][Full Text] [Related]
13. Enhanced lipid peroxidation and platelet activation as potential contributors to increased cardiovascular risk in the low-HDL phenotype.
Vazzana N; Ganci A; Cefalù AB; Lattanzio S; Noto D; Santoro N; Saggini R; Puccetti L; Averna M; Davì G
J Am Heart Assoc; 2013 Apr; 2(2):e000063. PubMed ID: 23557750
[TBL] [Abstract][Full Text] [Related]
14. Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease.
Mason PJ; Chakrabarti S; Albers AA; Rex S; Vitseva O; Varghese S; Freedman JE
Am J Cardiol; 2005 Nov; 96(10):1365-9. PubMed ID: 16275179
[TBL] [Abstract][Full Text] [Related]
15. Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin.
Lattanzio S; Santilli F; Liani R; Vazzana N; Ueland T; Di Fulvio P; Formoso G; Consoli A; Aukrust P; Davì G
J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25037197
[TBL] [Abstract][Full Text] [Related]
16. Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease.
Vazzana N; Santilli F; Lattanzio S; Liani M; Giacci L; Del Rosso G; Salvati F; Boccatonda A; Ferroni P; Davì G
Eur J Intern Med; 2016 Sep; 33():74-80. PubMed ID: 27389698
[TBL] [Abstract][Full Text] [Related]
17. Co-administration of nitric oxide-aspirin (NCX-4016) and aspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans.
Fiorucci S; Mencarelli A; Meneguzzi A; Lechi A; Renga B; del Soldato P; Morelli A; Minuz P
J Am Coll Cardiol; 2004 Aug; 44(3):635-41. PubMed ID: 15358033
[TBL] [Abstract][Full Text] [Related]
18. Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones.
Varo N; Vicent D; Libby P; Nuzzo R; Calle-Pascual AL; Bernal MR; Fernández-Cruz A; Veves A; Jarolim P; Varo JJ; Goldfine A; Horton E; Schönbeck U
Circulation; 2003 Jun; 107(21):2664-9. PubMed ID: 12742991
[TBL] [Abstract][Full Text] [Related]
19. Increased thromboxane biosynthesis in essential thrombocythemia.
Rocca B; Ciabattoni G; Tartaglione R; Cortelazzo S; Barbui T; Patrono C; Landolfi R
Thromb Haemost; 1995 Nov; 74(5):1225-30. PubMed ID: 8607099
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
